PLA2G2D anticorps (C-Term)
Aperçu rapide pour PLA2G2D anticorps (C-Term) (ABIN954162)
Antigène
Voir toutes PLA2G2D AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 112-138, C-Term
-
Specificité
- This antibody recognizes Human PLA2G2D (C-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 112-138 amino acids from the C-terminal region of human PLA2G2D
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- PLA2G2D (Phospholipase A2, Group IID (PLA2G2D))
-
Autre désignation
- PLA2G2D
-
Sujet
- Transposase-derived protein that may have nuclease activity (Potential). Does not have transposase activity.Synonyms: GIID sPLA2, Group IID secretory phospholipase A2, PLA2IID, Phosphatidylcholine 2-acylhydrolase 2D, Phospholipase A2 group IID, SPLASH, Secretory-type PLA stroma-associated homolog, sPLA2-IID
-
Poids moléculaire
- 16546 Da
-
ID gène
- 26279
-
NCBI Accession
- NP_036532
-
Pathways
- Inositol Metabolic Process
Antigène
-